Author

T. M. Ross

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 6 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 7 Assay:proteomics· 5 Research Focus:host-pathogen & immune response· 4 Organism:human· 4 Research Focus:cell type annotation· 3 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

H. Jang· 3 shared A. M. Jefferson· 2 shared D. Forgacs· 2 shared G. A. Sautto· 2 shared H. B. Hanley· 2 shared J. L. Gattiker· 2 shared A. B. Ward· 1 shared A. C. M. Boon· 1 shared

Activity by Year

2020-2025 · peak 5/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

H. Jang

Mutual co-authors in cluster

Author profile →

8 papers

Recent·Most cited

Delay of innate immune responses following influenza B virus infection affects the development of robust antibody response in ferrets

T. Rowe, A. Fletcher, R. A. Richardson, M. Lange, G. A. Sautto, G. A. Kirchenbaum, Y. Hatta, G. Jasso, D. E. Wentworth, T. M. Ross

This study shows that delayed innate immune responses to influenza B virus in ferrets lead to weaker antibody responses compared to influenza A virus.

mBio · Feb 5, 2025Peer-reviewedMicrobiology

The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccination

D. Forgacs, V. S. Moraes, H. B. Hanley, J. L. Gattiker, A. M. Jefferson, T. M. Ross

This study tracks antibody levels and memory B cell recall after SARS-CoV-2 infection or vaccination, finding that antibody waning occurs faster after vaccination than infection and that memory B cell recall can occur without detectable antibodies.

bioRxiv · Mar 16, 2022Immunology

The pre-existing human antibody repertoire to computationally optimized influenza H1 hemagglutinin vaccines

K. Nagashima, J. V. Dzimianski, J. Han, N. Abbadi, A. D. Gingerich, F. Royer, S. O'Rourke, G. A. Sautto, T. M. Ross, A. B. Ward, R. M. DuBois, J. Mousa

This study identifies pre-existing human B cell responses to computationally optimized H1 hemagglutinin vaccines, showing cross-reactivity and functional antibodies targeting head, central stalk, and anchor epitopes.

bioRxiv · Oct 25, 2021Immunology

Formulation of Dry Powders of Vaccines Containing MF59 or AddaVax by Thin-Film Freeze-Drying

K. AboulFotouh, N. Uno, H. Xu, C. Moon, S. Sahakijpijarn, D. J. Christensen, G. J. Davenport, C. Cano, T. M. Ross, R. O. Williams, Z. Cui

This study demonstrates that thin-film freeze-drying can convert MF59 or AddaVax-adjuvanted vaccines into dry powders while preserving immunogenicity and stability.

bioRxiv · Oct 21, 2021 · PreprintPharmacology & Toxicology

Functional characterization of SARS-CoV-2 vaccine elicited antibodies in immunologically naive and pre-immune humans

D. Forgacs, H. Jang, R. B. Abreu, H. B. Hanley, J. L. Gattiker, A. M. Jefferson, T. M. Ross

This study compares antibody responses to SARS-CoV-2 vaccination in pre-immune and immunologically naive individuals, finding higher neutralizing antibody levels in pre-immune participants.

bioRxiv · May 29, 2021Immunology

Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Pre-Immune to Seasonal Influenza A Viruses

Z. B. Reneer, A. L. Skarlupka, P. J. Jamieson, T. M. Ross

This study tests broadly reactive H2 HA vaccines in pre-immune ferrets, showing that pre-existing immunity enhances cross-reactive antibody responses and protection against swine H2N3 influenza.

bioRxiv · Feb 17, 2021Immunology

Hemagglutination Inhibition (HAI) Antibody Landscapes after Vaccination with diverse H7 hemagglutinin (HA) proteins

H. Jang, T. M. Ross

This study evaluates antigenic differences among H7 influenza HA proteins by vaccinating mice with VLPs and identifies key mutations affecting vaccine efficacy.

bioRxiv · Jan 25, 2021Immunology

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection

E. S. Winkler, P. Gilchuk, J. Yu, A. L. Bailey, R. E. Chen, S. J. Zost, H. Jang, Y. Huang, J. D. Allen, J. B. Case, R. E. Sutton, R. H. Carnahan, T. L. Darling, A. C. M. Boon, M. Mack, , M. Diamond

This study shows that neutralizing antibodies against SARS-CoV-2 need intact Fc functions and monocytes for optimal therapeutic protection in animal models.

bioRxiv · Dec 28, 2020Immunology